On Monday, Actinium Pharmaceuticals Inc (AMEX: ATNM) was -8.38% drop from the session before settling in for the closing price of $1.67. A 52-week range for ATNM has been $1.03 – $2.41.
Annual sales at Healthcare sector company grew by 21.99% over the past five years. When this article was written, the company’s average yearly earnings per share was at 2.76%. With a float of $30.22 million, this company’s outstanding shares have now reached $31.20 million.
Actinium Pharmaceuticals Inc (ATNM) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Actinium Pharmaceuticals Inc stocks. The insider ownership of Actinium Pharmaceuticals Inc is 3.12%, while institutional ownership is 20.00%.
Actinium Pharmaceuticals Inc (ATNM) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.37 earnings per share (EPS) during the time that was better than consensus figure (set at -0.37) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.76% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.20% during the next five years compared to 21.99% growth over the previous five years of trading.
Actinium Pharmaceuticals Inc (AMEX: ATNM) Trading Performance Indicators
You can see what Actinium Pharmaceuticals Inc (ATNM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.32, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -0.76 in one year’s time.
Technical Analysis of Actinium Pharmaceuticals Inc (ATNM)
Actinium Pharmaceuticals Inc (AMEX: ATNM) saw its 5-day average volume 0.6 million, a positive change from its year-to-date volume of 0.37 million. As of the previous 9 days, the stock’s Stochastic %D was 46.06%.
During the past 100 days, Actinium Pharmaceuticals Inc’s (ATNM) raw stochastic average was set at 30.23%, which indicates a significant decrease from 40.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0998 in the past 14 days, which was lower than the 0.1004 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6148, while its 200-day Moving Average is $1.4779. Nevertheless, the first resistance level for the watch stands at $1.6367 in the near term. At $1.7433, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.7967. If the price goes on to break the first support level at $1.4767, it is likely to go to the next support level at $1.4233. The third support level lies at $1.3167 if the price breaches the second support level.
Actinium Pharmaceuticals Inc (AMEX: ATNM) Key Stats
There are 31,196K outstanding shares of the company, which has a market capitalization of 47.73 million. As of now, sales total 0 K while income totals -38,240 K. Its latest quarter income was 0 K while its last quarter net income were -6,880 K.
